Page last updated: 2024-12-05
cyclohexamethylene carbamide
Description
Cyclohexamethylene carbamide, also known as hexamethylenetetramine (HMT), is a white crystalline organic compound with the formula (CH2)6N4. It is synthesized by reacting formaldehyde with ammonia. HMT is a versatile chemical with various applications, including as a pharmaceutical ingredient, a resin precursor, and a fuel additive. It is widely used in the production of plastics, explosives, and pharmaceuticals. HMT is a key intermediate in the production of other chemicals, such as melamine and hexamine. It is also used as a curing agent in epoxy resins and a crosslinking agent in polymers. The importance of HMT lies in its diverse industrial applications and its role as a building block for various chemical syntheses. It is studied for its potential applications in areas such as catalysis, materials science, and medicine. HMT has also been investigated for its antimicrobial and antiviral properties.'
cyclohexamethylene carbamide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 14283 |
CHEMBL ID | 366975 |
SCHEMBL ID | 26181 |
MeSH ID | M0067684 |
Synonyms (43)
Synonym |
unii-8a54a97ycr |
8a54a97ycr , |
4-09-00-00026 (beilstein handbook reference) |
EN300-31269 |
cyclohexyl carboxyamide |
brn 0507595 |
einecs 214-351-4 |
nsc 16584 |
cyclohexamethylene carbamide |
1122-56-1 |
hexahydrobenzoic acid amide |
nsc-16584 |
cyclohexylcarboxamide |
cyclohexanamide |
cyclohexylcarboxyamide |
nsc16584 |
cyclohexanecarboxamide |
cyclohexaneformamide |
inchi=1/c7h13no/c8-7(9)6-4-2-1-3-5-6/h6h,1-5h2,(h2,8,9 |
hexahydrobenzamide |
cyclohexanecarboxamide, 97% |
CHEMBL366975 |
cyclohexanecarboxylic acid amide |
AKOS001445426 |
A802524 |
FT-0624185 |
PS-4522 |
SCHEMBL26181 |
cyclohexane-carboxamide |
carbamoyl-cyclohexane |
cyclohexane-1-carboxamide |
1-cyclohexanecarboxamide |
cyclohexane carboxamide |
DTXSID1061528 |
mfcd00009693 |
W-108650 |
wm2 , |
bdbm50224864 |
Q27270087 |
CS-W013481 |
BAA12256 |
SY064829 |
Z33546516 |
Protein Targets (2)
Inhibition Measurements
Bioassays (3)
Assay ID | Title | Year | Journal | Article |
AID251619 | inhibition of Candida albicans was measured by zone diameter | 2004 | Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
| Screening of antimicrobial activity of diarylamines in the 2,3,5-trimethylbenzo[b]thiophene series: a structure-activity evaluation study. |
AID244826 | Minimal inhibitory concentration against Candida albicans | 2004 | Bioorganic & medicinal chemistry letters, Dec-06, Volume: 14, Issue:23
| Screening of antimicrobial activity of diarylamines in the 2,3,5-trimethylbenzo[b]thiophene series: a structure-activity evaluation study. |
AID33720 | In vitro inhibition against horse liver alcohol dehydrogenase | 1983 | Journal of medicinal chemistry, Jun, Volume: 26, Issue:6
| Inhibition by carboxamides and sulfoxides of liver alcohol dehydrogenase and ethanol metabolism. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.65
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 11.65 (24.57) | Research Supply Index | 2.48 (2.92) | Research Growth Index | 4.14 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |